SCHEMBL156015

SCHEMBL156015

CC(C)C(C#N)(COOP(N)O)C(C)C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1383854 0.81
SCHEMBL27439709 0.73
SCHEMBL156014 0.69
SCHEMBL992721 0.62
SCHEMBL29572856 0.62
SCHEMBL2154792 0.60
SCHEMBL3951490 0.60
SCHEMBL1954407 0.60
SCHEMBL27620689 0.60 TSHR (0.30)
SCHEMBL27984553 0.60

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 537 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4678646-A1 NUCLEOSIDE ANALOG FOR 5'-PHOSPHONATE MODIFICATION AND OLIGONUCLEOTIDE PREPARED THEREFROM Shanghai Argo Biopharmaceutical Co., Ltd. (CN) 2026-01-14 EP claimed
EP-4628583-A1 BICYCLIC ABASIC NUCLEIC ACID ANALOGS AND OLIGOMERIC COMPOUNDS PREPARED THEREFROM Shanghai Argo Biopharmaceutical Co., Ltd. (CN) 2025-10-08 EP claimed
EP-2885312-B1 METHOD OF PREPARING OLIGOMERIC COMPOUNDS USING MODIFIED CAPPING PROTOCOLS IONIS PHARMACEUTICALS INC (US) 2025-09-03 EP claimed
CN-116496326-A Process for the preparation of oligomeric compounds 南京金斯瑞生物科技有限公司 2023-07-28 CN claimed
EP-3119789-B1 BICYCLIC CARBOCYCLIC NUCLEOSIDES AND OLIGOMERIC COMPOUNDS PREPARED THEREFROM IONIS PHARMACEUTICALS INC (US) 2020-04-22 EP claimed
EP-3459962-A1 TRICYCLIC NUCLEOSIDES AND OLIGOMERIC COMPOUNDS PREPARED THEREFROM Universität Bern (CH) 2019-03-27 EP claimed
EP-2951191-B1 METHOD OF PREPARING OLIGOMERIC COMPOUNDS USING MODIFIED COUPLING PROTOCOLS IONIS PHARMACEUTICALS INC (US) 2018-10-17 EP claimed
US-10036019-B2 Bicyclic carbocyclic nucleosides and oligomeric compounds prepared therefrom IONIS PHARMACEUTICALS, INC. (US) 2018-07-31 US claimed
US-20180162897-A1 TRICYCLIC NUCLEOSIDES AND OLIGOMERIC COMPOUNDS PREPARED THEREFROM UNIVERSITAET BERN (CH) 2018-06-14 US claimed
US-9701708-B2 Method of preparing oligomeric compounds using modified coupling protocols IONIS PHARMACEUTICALS, INC. (US) 2017-07-11 US claimed
WO-2009006478-A2 6-DISUBSTITUTED BICYCLIC NUCLEIC ACID ANALOGS ISIS PHARMACEUTICALS, INC. (US) 2009-01-08 WO claimed
WO-2008154401-A2 CARBOCYCLIC BICYCLIC NUCLEIC ACID ANALOGS ISIS PHARMACEUTICALS, INC. (US) 2008-12-18 WO claimed
WO-2008150729-A2 N-SUBSTITUTED-AMINOMETHYLENE BRIDGED BICYCLIC NUCLEIC ACID ANALOGS ISIS PHARMACEUTICALS, INC. (US) 2008-12-11 WO claimed
EP-1984381-A2 6-MODIFIED BICYCLIC NUCLEIC ACID ANALOGS Isis Pharmaceuticals, Inc. (US) 2008-10-29 EP claimed
WO-2008101157-A1 5'-SUBSTITUTED-2'-F MODIFIED NUCLEOSIDES AND OLIGOMERIC COMPOUNDS PREPARED THEREFROM ISIS PHARMACEUTICALS, INC. (US) 2008-08-21 WO claimed
US-7399845-B2 6-modified bicyclic nucleic acid analogs ISIS PHARMACEUTICALS, INC. (US) 2008-07-15 US claimed
US-20070287831-A1 5'-MODIFIED BICYCLIC NUCLEIC ACID ANALOGS ISIS PHARMACEUTICALS, INC 2007-12-13 US claimed
WO-2007134181-A2 5'-MODIFIED BICYCLIC NUCLEIC ACID ANALOGS ISIS PHARMACEUTICALS, INC. (US) 2007-11-22 WO claimed
US-20070249049-A1 6-MODIFIED BICYCLIC NUCLEIC ACID ANALOGS FOUNDATION MEDICINE, INC. 2007-10-25 US claimed
WO-2007090071-A2 6-MODIFIED BICYCLIC NUCLEIC ACID ANALOGS ISIS PHARMACEUTICALS, INC. (US) 2007-08-09 WO claimed